Overview Financials News + Filings Key Docs Charts Ownership Insiders |
WALKER INNOVATION INC. (WLKR)
|
Add to portfolio |
|
|
Price: |
$0.50
| | Metrics |
OS: |
20.1
|
M
| |
|
|
Market cap: |
$10
|
M
| |
|
|
Net cash:
|
|
| |
|
|
EV:
|
$10
|
M
| | | |
| | | | | |
TTM Valuation | | | |
EBITDA
|
$2.3
|
M
| |
4.4
|
x EV/EBITDA
|
EBIT
|
|
| |
|
|
EPS |
($0.11)
| |
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
In millions, except per share items | Dec-31-17 | Dec-31-16 | Dec-31-15 | Dec-31-14 | Dec-31-13 | Dec-31-12 | Dec-31-11 | Dec-31-10 |
Revenues | 0.3 | 4.3 | 2.3 | 2.9 | 2.1 | 32.3 | 0.0 | 0.0 |
Revenue growth | -93.0% | 84.8% | -21.5% | 40.9% | -93.5% | | | |
Cost of goods sold | 1.7 | 1.8 | 1.6 | 0.9 | 0.8 | 14.4 | 0.0 | 0.0 |
Gross profit | -1.4 | 2.5 | 0.7 | 2.1 | 1.3 | 17.9 | 0.0 | 0.0 |
Gross margin | -474.0% | 57.8% | 29.8% | 70.1% | 64.1% | 55.4% | | |
Selling, general and administrative | 3.4 | 6.0 | 9.0 | | 5.3 | | | |
Sales and marketing | | | | 0.3 | | | | 1.8 |
Research and development | | | | | | 2.4 | | |
General and administrative | | 2.2 | 3.7 | 4.4 | 2.1 | 3.4 | 3.0 | 14.1 |
EBIT | -0.5 | 3.4 | -8.7 | -10.0 | -5.0 | 11.3 | -3.0 | -15.9 |
EBIT margin | -179.0% | 80.2% | -375.8% | -337.9% | -239.0% | 35.0% | | |
Pre-tax income | -0.5 | 16.9 | -6.2 | -15.6 | -14.4 | 11.3 | -3.0 | -16.1 |
Income taxes | 0.4 | 0.0 | 4.2 | 0.0 | 0.0 | 0.0 | -2.6 | -0.8 |
Tax rate | | 0.0% | | 0.0% | 0.0% | 0.0% | 88.3% | 5.2% |
Earnings from continuing ops | -0.9 | 16.9 | -10.4 | -15.6 | -14.4 | 11.3 | -3.0 | -16.1 |
Earnings from discontinued ops | | | | | | | 2.6 | 0.8 |
Net income | -0.9 | 16.9 | -10.4 | -15.6 | -14.4 | 11.3 | -0.3 | -15.3 |
Net margin | -297.0% | 394.5% | -449.3% | -529.8% | -686.9% | 35.0% | | |
|
Diluted EPS | ($0.04) | $0.47 | ($0.50) | ($0.76) | ($1.29) | $0.50 | ($0.33) | ($1.13) |
Shares outstanding (diluted) | 20.5 | 36.0 | 20.7 | 20.4 | 11.1 | 22.7 | 9.1 | 14.3 |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|